Last reviewed · How we verify
Enterobacter Pneumonia
Approved treatments
- MEZLOCILLIN
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Garamycin · Merck & Co.
- Tobi · Novartis
- Maxipime · Baxter
Cefepime is a cephalosporin antibacterial drug. - Claforan · Sterimax
- Maxipime · Baxter
Cefepime is a cephalosporin antibacterial drug that inhibits bacterial cell wall synthesis. - Pipracil
Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death. - Cefepim · University Hospital Tuebingen
- Ciprofloxacine · Poitiers University Hospital
- Vantobra · Pfizer
- Gentamicin · Merck & Co.
- Nebcin · University Hospital, Lille
- Ceftriaxon · Centre Hospitalier Universitaire Vaudois
- Azactam · Bristol-Myers Squibb
Aztreonam inhibits bacterial cell wall synthesis, acting as a bactericidal agent. - Primaxin · Merck Sharp & Dohme B.V.
Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Arikayce Kit · Bristol-Myers Squibb
Amikacin works by binding to bacterial ribosomes, inhibiting protein synthesis and ultimately killing the bacteria. - Fortaz · Pai Holdings Pharm
Fortaz works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death. - Primaxin · Merck & Co.
Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body. - AZLOCILLIN · Bayer Pharmaceuticals Corp
- TICARCILLIN
- Ticarcillin
- Fortaz · Pai Holdings Pharm
Bactericidal agent inhibiting bacterial cell wall synthesis with beta-lactamase resistance. - Noroxin
- Floxin
- Epocelin
- Cipro · Bayer AG
- Rocephin · Generic (originally Roche)
- Ceftazidim · Tel-Aviv Sourasky Medical Center
- Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Enterobacter Pneumonia patent landscape — cliff calendar, originator estates, attackable patents
- Enterobacter Pneumonia treatment landscape brief
- Enterobacter Pneumonia treatment updates RSS
Frequently asked questions about Enterobacter Pneumonia
What drugs treat Enterobacter Pneumonia?
Tracked treatments include MEZLOCILLIN, Ramycin, Garamycin, Tobi, Maxipime, Claforan, Pipracil, Cefepim.
What is the treatment for Enterobacter Pneumonia?
Standard treatment for Enterobacter Pneumonia includes MEZLOCILLIN, Ramycin, Garamycin, Tobi, Maxipime. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Enterobacter Pneumonia patent cliff · Enterobacter Pneumonia CI report
- Treatment: MEZLOCILLIN
- Treatment: Ramycin
- Treatment: Garamycin · Merck & Co.
- Treatment: Tobi · Novartis
- Treatment: Maxipime · Baxter
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing